The use of tricyclic antidepressants in the treatment of temporomandibular joint disorders: systematic review of the literature of the last 20 years.
Many therapies have been proposed for the management of temporomandibular disorders, including the use of different drugs. However, lack of knowledge about the mechanisms behind the pain associated with this pathology, and the fact that the studies carried out so far use highly disparate patient selection criteria, mean that results on the effectiveness of the different medications are inconclusive. This study makes a systematic review of the literature published on the use of tricyclic antidepressants for the treatment of temporomandibular disorders, using the SORT criteria (Strength of recommendation taxonomy) to consider the level of scientific evidence of the different studies. Following analysis of the articles, and in function of their scientific quality, a type B recommendation is given in favor of the use of tricyclic antidepressants for the treatment of temporomandibular disorders.
Cascos-Romero
Jordi
J
Oral Surgery and Implantology Master Degree Program, College of Dentistry of the University of Barcelona, Spain.
Vázquez-Delgado
Eduardo
E
Vázquez-Rodríguez
Eduardo
E
Gay-Escoda
Cosme
C
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D006801:Humans; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy*; D013997:Time Factors
D000929:Antidepressive Agents, Tricyclic